No, Eliquis (apixaban) is NOT contraindicated when starting Depakote (valproic acid) for mood stabilization
There is no pharmacological interaction or contraindication between apixaban and valproic acid, and these medications can be safely used together. The FDA label for Eliquis lists only active pathological bleeding and severe hypersensitivity reactions as absolute contraindications 1. Valproic acid does not appear in any drug interaction warnings for apixaban.
Key Pharmacological Considerations
Apixaban Metabolism and Drug Interactions
Apixaban is metabolized primarily through CYP3A4 and P-glycoprotein (P-gp) pathways 2. The drug interactions of concern involve:
- Strong dual CYP3A4 and P-gp inhibitors (e.g., ketoconazole, clarithromycin) - which increase apixaban levels
- Strong CYP3A4 or P-gp inducers (e.g., rifampin, carbamazepine, phenytoin) - which decrease apixaban levels 3, 2, 4
Valproic Acid Does Not Affect These Pathways
Valproic acid is not a significant inducer or inhibitor of CYP3A4 or P-gp 5. While valproic acid does interact with other anticonvulsants through protein binding displacement and metabolic inhibition, these mechanisms do not affect apixaban pharmacokinetics 5.
Clinical Monitoring Recommendations
While the combination is safe, standard monitoring for each medication should continue:
For Apixaban:
- Monitor for bleeding complications (the primary risk with any anticoagulant)
- Be aware that valproic acid can cause thrombocytopenia as an adverse effect 6, which could theoretically increase bleeding risk independent of apixaban
- No dose adjustment of apixaban is needed
For Valproic Acid (Depakote):
- Standard therapeutic monitoring for mood stabilization
- Monitor for common side effects: tremor, weight gain, sedation 7
- Obtain baseline and periodic liver function tests and complete blood counts 6
Important Caveat: Bleeding Risk Considerations
The main clinical concern is additive bleeding risk rather than a drug-drug interaction:
- Valproic acid can cause thrombocytopenia and platelet dysfunction 6
- Apixaban is an anticoagulant with inherent bleeding risk
- Monitor platelet counts when using this combination, especially during the first few months of valproic acid therapy
- Watch for signs of abnormal bleeding (bruising, petechiae, epistaxis) 8
Mood Stabilization Context
Valproic acid (Depakote) is an appropriate choice for mood stabilization in bipolar disorder 7. The presence of anticoagulation therapy does not preclude its use, though alternative mood stabilizers (lithium, lamotrigine, atypical antipsychotics) could be considered if bleeding concerns arise 7.
The combination can be used safely with appropriate clinical monitoring for bleeding and thrombocytopenia.